Our data show that atorvastatin, administered 3 hours after the induction of sepsis, is able to improve the survival curve, attenuating higher levels of IL-6 and TNF-α and reduce insulin resistance, as demonstrated during the insulin tolerance test. This evidence concerns the gene TNF and Insulin resistance.